ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 22 filers reported holding ENZYMOTEC LTD in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 202,962 | $5,482,000 | 1.66% |
| Visium Asset Management, LP | 690,000 | $18,637,000 | 0.37% |
| ALYDAR PARTNERS LLC | 90,000 | $2,431,000 | 0.25% |
| Paulson & Co. | 1,733,030 | $46,809,000 | 0.23% |
| GILDER GAGNON HOWE & CO LLC | 218,232 | $5,894,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 83,971 | $2,268,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,000 | $270,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,450 | $148,000 | 0.03% |
| TFS CAPITAL LLC | 9,736 | $263,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 208,806 | $5,640,000 | 0.01% |